- CRSP +1.79%
Search results
- 47.32Add to watchlist+0.83 (+1.79%)At close:4:00 PM EDTFri. Sep 27, 202447.45 +0.13 (+0.27%)After hrs:6:29 PM EDTFri. Sep 27, 2024Nasdaq Real Time Price (USD) · Market closed
- Open47.18High47.62Low46.70
- Mkt. Cap4.03BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close46.4952 Wk. Low37.5552 Wk. High91.10
What analysts are sayingTop StoriesCRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short SellersYahoo Finance · 3 weeks agoRelated stocks
4 days ago · CRSP is a biotech company developing gene editing therapies for rare diseases. See its stock price, fair value, news, financials, valuation, and competitors.
- 15.73
- 0.00
1 day ago · A high-level overview of CRISPR Therapeutics AG (CRSP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
People also ask
Is CRSP (CRSP) a good stock to buy?
Is CRISPR Therapeutics AG (CRSP) a good stock to buy?
What does CRSP stand for?
Does CRISPR Therapeutics AG (CRSP) pay a dividend?
2 days ago · Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
4 days ago · Get a real-time CRISPR Therapeutics AG (CRSP) stock price quote with breaking news, financials, statistics, charts and more.
- 4.23B
- 202.23M
- 265.80M
- 88.52M
1 day ago · CRSP's current price target is $75.63. Learn why top analysts are making this stock forecast for CRISPR Therapeutics at MarketBeat.
- susan.kim@crisprtx.com
Sep 19, 2024 · CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.49, moving -0.2% from the previous trading session. This change lagged the S&P 500's 1.7% gain on the day.
3 days ago · Should You Buy or Sell CRISPR Therapeutics Stock? Get The Latest CRSP Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.